Improve Medical Instrumentsに関するコメント

Improve Medical Instruments' P/S remains low despite share price increase, due to medium-term revenue decline. Investors doubt potential revenue improvement justifies higher P/S ratio. Share price unlikely to significantly move if revenue trends persist.

Investors believe the company will underperform the broader industry, leading to a low P/S ratio. The company's shrinking revenue and the industry's projected growth are key factors. Shareholders accept the low P/S, conceding future revenue probably won't surprise. If recent trends continue, the share price may not move strongly in either direction.